glp-1 therapy san antonio - K&E MEDSPA | Weight Loss Clinic Semaglutide GLP-1 Specialist Near Me

The introduction of GLP-1 therapeutics has revolutionized the treatment of type 2 diabetes and obesity, with other potential indications under investigation

Clinical studies on FDA-approved GLP-1 receptor agonists have shown that the most significant weight loss typically occurs between 16 and 48 weeks of consistent use

Kakegawa T, Sugimoto K, Saito K, Yunaiyama D, Araki Y, Wada T, et al

Intracellular signaling leads to the hypertrophic effect of neuropeptide Y

A large cardiovascular outcomes trial found that higher proportions of tirzepatide recipients reported vomiting, diarrhea, and nausea compared to those taking a selective GLP-1RA